Clinical Trials on HIV-infektiot

Total 24567 results

University of Connecticut
National Institute of Mental Health (NIMH)

Completed

HIV Internet Sex Study: Internet-based STI/HIV Prevention for HIV+ Internet Users (HINTS)

Risk Reduction | HIV-1 Infection
National Institute of Allergy and Infectious Diseases...

Withdrawn

A Study of Patients Who Recently Have Been Infected With HIV

HIV Infections

United States
United Biomedical
Taipei Veterans General Hospital, Taiwan; Kaohsiung Veterans General Hospital. and other collaborators

Completed

Study to Evaluate Safety and Efficacy of UB-421 Antibody in HIV-1 Infected Adults

HIV-1 Infection in Adults

Taiwan
National Institute for Medical Research, Tanzania

Unknown

Cash Transfer to Adolescent Girls and Young Women to Reduce Sexual Risk Behavior - an Impact Evaluation (CARE)

HIV/AIDS | HSV-2 Infection

Tanzania
Lund University
Ethiopian Public Health Institute; Armauer Hansen Research Institute, Ethiopia and other collaborators

Recruiting

HIV Transmission in the Era of Scaling up Antiretroviral Therapy in Ethiopia (THESA)

Antiretroviral Therapy | HIV-1-infection

Ethiopia
Florida International University
National Institute of Mental Health (NIMH)

Active, not recruiting

Personalized Prevention for Couples: A 16-month Digital RCT (LuvHub)

HIV Infections | Sexually Transmitted Diseases | Hiv | Sexual Behavior | Risk Reduction | Sexually Transmitted Infection

United States
Universita di Verona

Not yet recruiting

Nivolumab/Ipilimumab and Chemotherapy Combination in Advanced NSCLC Patients With HIV, HBV, HCV and Long Covid Syndrome (LUNGVIR)

HIV | HBV | Long COVID | NSCLC Stage IV | HCV

Italy
David Garcia Cinca
Fundacion Clinic per a la Recerca Biomédica

Unknown

Simplification Study of HIV-1 Infected Patients With Virological Suppression Under the Combination of Lamivudine (150 mg BID) Plus Raltegravir (400 mg BID) Switching to Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) : Roll-over Study of the RALAM (RALAM-RollOver)

HIV Infections | HIV Seropositivity | HIV-1-infection

Spain
David Garcia Cinca
Fundacion Clinic per a la Recerca Biomédica

Unknown

Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen (RALAM-II)

HIV Infections | HIV Seropositivity | HIV-1-infection

Spain
South East Asia Research Collaboration with Hawaii
Merck Sharp & Dohme LLC; Pfizer; Gilead Sciences; Thai Red Cross AIDS Research... and other collaborators

Recruiting

Antiretroviral Therapy for Acute and Chronic HIV Infection (AAHIV)

Acute HIV Infection | Chronic HIV Infection

Thailand
National Institute of Allergy and Infectious Diseases...
Bristol-Myers Squibb

Completed

Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients

HIV Infections

United States, Brazil
National Institute of Allergy and Infectious Diseases...
The Immune Response Corporation

Terminated

Effectiveness of Adding Remune to Your Current Anti-HIV Drug Combination

HIV Infections

United States
Rockefeller University

Completed

Phase I/II, Open-Label Trial of Three Monoclonal Antibodies

HIV Infections

United States
Merck Sharp & Dohme LLC

Completed

A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM4)

HIV Infections | Hepatitis C | HCV Infection
New York University
NYU Langone Health

Unknown

Adherence Connection for Counseling, Education, and Support (ACCESS)

HIV-infection/AIDS

United States
Tobira Therapeutics, Inc.
ViiV Healthcare

Completed

Study of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of Midazolam

HIV-infection/AIDS

United States
ANRS, Emerging Infectious Diseases
University College London Hospitals; Hospital Clinic of Barcelona; Imperial College... and other collaborators

Completed

A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02)

HIV-1-infection

France, United Kingdom, Switzerland
Henry M. Jackson Foundation for the Advancement...
US Military HIV Research Program; Janssen Vaccines & Prevention B.V.

Withdrawn

Safety and Efficacy of Neutralizing Antibodies and Vaccination for Induction of HIV Remission (RV582)

HIV-1-infection

Thailand
The Wistar Institute
University of Pennsylvania; Merck Sharp & Dohme LLC

Completed

Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV

HIV-1 Infection

United States
Gilead Sciences

Completed

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of E/C/F/TAF Fixed Dose Combination (FDC) in HIV-1 Infected Adults on Chronic Hemodialysis

HIV-1 Infection

United States, France, Austria, Germany
Assiut University

Completed

Hepatitis D Virus Infection Among Hepatitis B Virus Surface Antigen Positive Individuals

HDV Infection | HBV Infection
National Institute of Allergy and Infectious Diseases...

Completed

Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in HIV

HIV Infections

United States
University of California, Los Angeles
University of California, San Francisco

Completed

Contingency Management for PrEP Adherence and/or Methamphetamine Use (C-MAX)

Methamphetamine-dependence | HIV-1-infection

United States
Haitian Group for the Study of Kaposi's Sarcoma...
Harvard Medical School (HMS and HSDM); Brigham and Women's Hospital; Weill Medical... and other collaborators

Unknown

Continuation of Protease-Inhibitor Based Second-Line Therapy vs. Switch to B/F/TAF in Virologically Suppressed Adults

Antiretroviral Therapy | HIV-1-infection

Haiti
Weill Medical College of Cornell University
AdhereTech

Completed

HIV Adherence Bottle Intervention Trial (HABIT)

Adherence, Medication | HIV-1-infection
Washington University School of Medicine

Withdrawn

Maraviroc on HIV-1 Infected Subjects Who Require Allogeneic Hematopoietic Cell Transplant

HIV-1-infection
Abdul Latif Jameel Poverty Action Lab
Innovations for Poverty Action

Completed

The Impact of VCT and Condom Distribution as HIV Prevention Strategies Among Youth in Kenya

HIV/AIDS | HSV-2 Infection
Columbia University
Merck Sharp & Dohme LLC; Jhpiego

Active, not recruiting

HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini

Hiv | HPV Infection | HPV Vaccine

Swaziland
Academisch Medisch Centrum - Universiteit van Amsterdam...
Public Health Service of Amsterdam

Active, not recruiting

Comorbidity and Aging With HIV (agehIV)

HIV-1-infection | Ageing | Comorbidity

Netherlands
Yunnan AIDS Care Center

Unknown

Safety and Efficacy of Raltegravir+TDF+3TC in HBV/HIV Co-infected Patients

HIV Infections | HBV Coinfection

China
Vastra Gotaland Region
Göteborg University; Halmstad University; RISE - Research Institutes of Sweden; CRC Medical AB and other collaborators

Unknown

Wound Contamination During Orthopaedic Surgery (Clean Care)

Hip Fractures | Surgical Site Infection | Orthopedic Disorder | Implant Infection

Sweden
University Hospital, Ghent
KU Leuven; Universitair Ziekenhuis Brussel; Vrije Universiteit Brussel; Centre... and other collaborators

Not yet recruiting

Immuno-virological Evaluation of Persons Living With HIV (PLWH)

HIV Seropositivity | HIV-1-infection

Belgium
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Sitagliptin for Reducing Inflammation and Immune Activation

HIV-1 Infection

United States
University Health Network, Toronto
CIHR Canadian HIV Trials Network

Terminated

Probiotic Visbiome for Inflammation and Translocation in HIV Ι (PROOV IT I)

HIV-1 Infection

Canada
University of Chile
ViiV Healthcare

Unknown

Proviral DNA as a Target for HIV-1 Resistance Analysis (HIV)

HIV Infections | HIV/AIDS | HIV Seropositivity | Viral Infection

Chile
ANRS, Emerging Infectious Diseases
Merck Sharp & Dohme LLC; Pfizer; Gilead Sciences; Janssen-Cilag Ltd.

Completed

Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM)

HIV-1 Infections

France
Florida International University

Completed

Growing Up: Intervening With HIV-Positive Adolescents in Resource-Poor Settings

HIV Infection

Haiti
University of Zurich

Unknown

Early Simplified: A Trial to Compare the Efficacy of Standard of Care Combination Antiretroviral Therapy With a Simplified Dolutegravir Monotherapy in Patients With a Primary HIV-1 Infection

Treatment Efficacy | Monotherapy | Dolutegravir | Primary HIV Infection

Switzerland
Fundacion Clinic per a la Recerca Biomédica

Unknown

Clinical Trial to Evaluate the Efficacy, Pharmacokinetics (PK) Interactions and Safety of Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in HIV-1-Infected Solid Organ Transplant Patients

HIV-1-infection | Solid Organ Transplant

Spain
Pedro Cahn
Merck Sharp & Dohme LLC

Unknown

RAL+ATV/r in Comparison With TDF/FTC (or 3TC) +ATV/r in HIV Infected Patients (ARTE)

Chronic Infection With HIV

Argentina
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate

HIV-1 Infection

United States
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Withdrawn

Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation

HIV-1 Infection

United States
Peking Union Medical College
Ministry of Science and Technology of the People´s Republic of China

Unknown

Study on the Impact of Triptolide Woldifiion on HIV-1 Reservoir In Acute HIV-1 Infection

AIDS/HIV PROBLEM

China
TaiMed Biologics Inc.
Bill and Melinda Gates Foundation; Aaron Diamond AIDS Research Center

Completed

Safety Study of Ibalizumab Subcutaneous Injection in Healthy Volunteers (TMB-108)

Prevention of Infection With HIV-1

United States
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected Mothers

HIV Infection | Rotavirus Infection

Botswana, Zimbabwe, Zambia, Tanzania
Biomedical Research and Training Institute, Zimbabwe
Gilead Sciences

Completed

Community Based Antiretroviral Therapy (CBART) Among Children on Chronic ART (CBART)

HIV I Infection | ART

Zimbabwe
Hennepin Healthcare Research Institute

Completed

Targeted Anticoagulation Therapy to Reduce Inflammation and Cellular Activation in Long-term HIV Disease (TACTICAL-HIV)

HIV Infection | Inflammation | Coagulation

United States
University of Modena and Reggio Emilia

Unknown

My Smart Age With HIV: Smartphone Self-assessment of Frailty (MySAwH)

HIV Infection | Aging

Italy
Montefiore Medical Center
Centers for Disease Control and Prevention

Completed

Peer Outreach and Navigation Intervention to Increase PrEP Uptake Among Women at High Risk for HIV

HIV-1-infection | Pre-exposure Prophylaxis

United States
University Health Network, Toronto
CIHR Canadian HIV Trials Network

Unknown

Probiotic Visbiome for Inflammation and Translocation in HIV II (PROOV IT II)

HIV-1 Infection

Canada

Clinical Trials on HIV-infektiot

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations